Skip to main content

Breast Cancer Drug Recalled

June 27, 2019

American Health Packaging is recalling 15,386 cartons of anastrozole tablets, 1 mg, 30-count unit dose blisters per carton (NDC 60687-112-21). According to the June 26, 2019, US Food and Drug Administration (FDA) Enforcement Report, the recall was initiated due to the potential for cross-contamination from a cleaning procedure failure. 

The recall affects anastrozole tablets from lots 175289A, 175286B, and 175290B (Exp. 8/31/19); 179906A (Exp. 3/31/20); 183252A (Exp. 9/30/20); and 184611A (Exp. 11/30/20). The tablets were distributed within the United States. 

American Health Packaging voluntarily initiated the recall May 9, 2019. On June 19, 2019, the FDA designated it Class II, signaling use of the tablets could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists. 

Anastrozole is a prescription medication used to treat breast cancer in women after menopause. 

Jolynn Tumolo

Back to Top